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 This paper explores the connections between needle exchange programs and rates of 
HIV/AIDS in Switzerland and the United States of America. While these two countries are very 
similar in their general political philosophies, they have some key cultural and historical 
differences which has shaped their responses to HIV/AIDS and injection drug use. Switzerland’s 
unique experience with a very open injection drug use scene in the 1980s guided this country to a 
more pragmatic, harm reduction-based response. By contrast, United States responded to the 
AIDS epidemic that struck violently in the 1980s with a mix of fear and denial. Though both 
generally conservative countries, Switzerland has a history of being independent and pragmatic. 
The U.S., on the other hand, has built an international identity on its Puritanical roots and seeks 
global influence through repressive drug measures. As such, needle exchange programs have 
been widely implemented in Switzerland but their growth is stunted in the United States. The 
unfortunate result is that the USA has not been able to contain injection drug use or the AIDS 
epidemic to anywhere near the same extent has Switzerland.  
 All the experts interviewed for this paper were speaking with regards to their own 
personal opinion. Their statements in no way reflect the official positions of the organizations for 











List of Abbreviations  
 
· AIDS: Acquired Immune Deficiency Syndrome  
· CDC: Center for Disease control  
· CHUV: Centre Hospitalier Universitaire Vaudois 
· COROMA: Collège Romand de Médicine de l'Addiction 
· HIV: Human Immunodeficiency Virus 
· IDU: Injection Drug User  
· NEP: Needle Exchange Program  
· NHAS: National HIV/AIDS Strategy  
· NSP: Needle and Syringe Program 
· SAF: Swiss Aids Federation  
· SEP: Syringe Exchange Program 
· UNAIDS: Joint United Nations Programme on HIV/AIDS 
· UNDP: United Nations Development Programme  
· USA, US: United States of America  
· WHO: World Health Organization  










Literature Review  
 Needle Exchange Programs (NEPs) are an undoubtedly controversial component of the 
harm reduction framework. Many countries continue to outlaw these types of programs despite 
the fact that there exists a general consensus amongst most experts that these programs are 
effective and do not result in other, deleterious effects. Countries such as the U.S., which is very 
influential within the UN system, “Japan, Sweden, many ex-Soviet states and most Arab and 
African nations” feverishly support prohibitive approaches to global drug control.1 However, 
sentiments are shifting in Europe where many countries are “increasingly at odds with some 
sectors of the UN drug control system” because of their support for harm reduction-based 
approaches.2  
These controversies and global debates persist despite the fact that many organizations, 
including the WHO, support Needle and Syringe Programs as a “fundamental component of any 
comprehensive and effective HIV-prevention programme” because of their ability to 
significantly reduce the transmission of HIV associated with injection drug use.3 According to a 
report by the Global Commission on Drug Policy, countries that have followed a harm reduction 
framework “have experienced consistently low rates of HIV transmission” among injection drug 
users (IDUs).4 In 2004, the WHO released a report of their findings after a comprehensive study 
of existing literature on NEPs. Among their many conclusions, the WHO stated that NSPs are 
“cost-effective and cost-saving” programs and that they were able to find “no convincing 
evidence” of “unintended complications associated with NSPS” such as increased drug 
                                                 
1 Bewley-Taylor, “Getting High on the Policy Agenda.”p.35  
2 Ibid. p.28  
3 Wodak and Cooney, “Effectivness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS 
Among Injecting Drug Users.” p.5  
4 “War on Drugs.”p.6  
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consumption, maintenance of addiction, or higher numbers of discarded syringes in the 
communities surrounding NSPs.5 Emmanuel Ducret, the Executive Director of Premiere Ligne, a 
NEP in Geneva, supported this information through the experiences of his own organization. 
Premiere Ligne is able to recover 98% of all syringes that it distributes, both through people 
returning them to the center and by teams that walk through the streets during the day to collect 
the needles.6 Thus, the concerns surrounding needle exchanges seem to be founded in a fear of 
drugs and drug users rather than in the reality of the situation.  
  The implementation of NEPs in many countries and localities is fraught with political 
implications and is often met with resistance from the surrounding community. Political and 
social factors “can be more important than epidemiologic data” in influencing decisions around 
public health policies.7 A study by Beletsky, Macalino, and Burris illustrated the resistance of 
police officers in Rhode Island, USA to support such programs. The perceptions of police 
officers are also quite important because they “exercise a great deal of discretion in their work” 
and can act in ways that are inconsistent with official policies.8 Though officers in this study 
agreed that social factors contributed heavily to drug use and dependence they did not feel that 
social environment was enough to “absolve IDUs of responsibility for drug abuse and criminal 
behaviour.”9 Beletsky et. al. note that officers are “in a better position” than the rest of society 
                                                 
5 Wodak and Cooney, “Effectivness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS 
Among Injecting Drug Users.” p.15 and p.16  
6 Ducret, Formal Interview with Premiere Ligne. 
7 Des Jarlais, “Research, Politics, and Needle Exchange.” p.1392  
8 Beletsky, Macalino, and Burris, “Attitudes of Police Officers towards Syringe Access, Occupational 
Needle-Sticks, and Drug Use: A Qualitative Study of One City Police Department in the United 
States.”p.268  
9 Ibid. p.271  
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“to see the complexities of drug use and control,” especially with regards to the ways in which 
drug use affects individuals and communities.10  
  Some resistance to needle exchange programs originates from early experiments 
conducted in Vancouver and Montreal. The first papers published about these programs seemed 
to indicate an “apparent failure” of the NEP programs in Canada, some of the first in North 
America.11 While these studies indicated that HIV rates in clients at these particular NEPs were 
increasing, they did not account for the fact that IDUs attending NEPs were among the most 
vulnerable populations in society and thus had drastically higher odds of contracting HIV. The 
detractors from these programs also often fail to account for the structural failings of the 
Vancouver and Montreal programs, such as limited operating hours and small geographic 
coverage which resulted in a “significant proportion” of clients experiencing “difficulty 
accessing sterile syringes” and thus severely hindered the ability of these programs to be 
efficacious.12 
 Dr. Roel A. Coutinho falls into a similar trap with his piece “Needle Exchange, 
Pragmatism, and Moralism.” He cites the Vancouver and Montreal studies to support his 
findings that there is “no effect on seroconversion for HIV from needle exchange use” and that 
NEPs have “no protective effect” against HIV, hepatitis C, and hepatitis B.13 He, like other 
detractors, fails to consider the contextual factors surrounding any needle exchange program. 
More intensive studies by the WHO and other organizations have found a preponderance of 
evidence that allows us to “reject the null hypothesis that attendance at NSP does not confer 
                                                 
10 Ibid. p.272  
11 Hyshka et al., “Needle Exchange and the HIV Epidemic in Vancouver: Lessons Learned from 15 Years 
of Research.” p.263  
12 Ibid. p.264  
13 Work, “Needle Exchange, Pragmatism, and Moralism.” P.1388  
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protection against HIV” for injection drug users.14 Furthermore, a 2012 report by the La 
Commission Mondiale Pour la Politique Des Drogues (UNODC) claims that “la guerre contre la 
drogue ait favorisé la propagation du VIH dans de nombreuses régions” of the world. 15 
Unfortunately, a 2011 report by the UNODC highlights that those targeted by the War on Drugs, 
such as users and low-level sellers or growers, “are themselves the victims of violence and 
intimidation” because they are typically in the lowest rungs of the drug-market hierarchy.16  As 
such, the continued debate on the efficacy of these programs is not only misguided but actually 
quite harmful.   
 Though some try to hide behind doubts about the efficacy of these programs as the main 
reason for their reluctance to accept these programs, the reality is that NEPs raise moralistic 
questions that divide the general public. In general, governments and individuals tend view 
needle exchanges as “condoning drug use” and letting drug users continue their morally 
unacceptable behaviors.17 It is also important to note that harm reduction programs “have a 
critical moral component” to them.18 Supporters of this philosophy of public health are taking a 
moral stance about the “sphere of individual autonomy” and human rights with regards to drug 
use.19 As such, both supporters and detractors of needle exchange programs are not arguing 
solely on the level of scientific fact and accuracy. Rather, they are also debating moral and 
ethical questions about law, individual rights, and community responsibilities.  
                                                 
14 Wodak and Cooney, “Effectivness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS 
Among Injecting Drug Users.” p. 11  
15 “La Guerre Aux Drogues Face Au VIH/sida: Comment La Criminalisation de L’usage de Drogues 
Aggrave La Pandémie Mondiale.” p.2  
Courtesy translation by author: The war against drugs has favored the propagation of HIV in many 
regions of the world  
16 “War on Drugs.” p.6  
17 Work, “Needle Exchange, Pragmatism, and Moralism.” p. 1387  
18 Des Jarlais, “Research, Politics, and Needle Exchange.” p.1394  
19 Buchanan et al., “Empirical Science Meets Moral Panic: An Analysis of the Politics of Needle 
Exchange.” p.435  
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Research Questions  
 Though official sister nations, and quite similar in many regards, the United States of 
America and Switzerland have chosen significantly different tactics in order to address drug use 
within their countries. The primary purpose of this research project is to determine the ways in 
which these countries diverge from each other in respond to injection drug use and how these 
varying policies have resulted in different outcomes regarding HIV/AIDS in the two countries. 
However, perhaps more importantly, this paper is centered on the historical, cultural, and 
political differences between Switzerland and the USA in order to determine the root causes of 
their varying policies. In this paper, I argue that the repression-based policies of the US and the 
harm reduction-focused efforts of Switzerland can be linked to fundamental differences in the 
historical contexts of the two countries. These countries were presented with similarly severe 
situations, HIV/AIDS in the US and open drug use in Switzerland, but political and cultural 
legacies caused them drastically different responses.  
 Very few other papers have directly compared the fundamental cultural and political 
bases in the USA and Switzerland that shaped their responses to the growing pandemics of drug 
use and AIDS. While extensive work has been done in each country to monitor the situations of 
AIDS and drug use, there is a definite lack of research that seeks to identify the fundamental 
historical, cultural, and political structures that vary within each country and have had a direct 
impact on the present outcomes of these health crises. This paper features an analysis of 
historical contexts and how they caused these otherwise very similar countries to diverge in 
terms of drug policy.  
Research Methodology  
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 This paper features a combination of primary and secondary research. Primary research 
consisted of individual interviews with experts in the areas of harm reduction and HIV/AIDS. 
Those interviewed were primarily directors of programs or organizations who work directly in 
one of the following domains in Switzerland: Harm reduction, HIV/AIDS, injection drug use, or 
addiction. Experts were identified based on their affiliation with an organization or through the 
recommendation by another expert in the field. The major organizations working with AIDS and 
NEPs were identified through internet searches and through their own publicly-available 
advertising in organizations frequented by homosexual men (who are most at risk for contracting 
HIV in Switzerland at the current moment) and injection drug users. Experts were either 
contacted directly, if their information was available on line, or by first contacting the 
organization generally in the case that no one person was identified online. Formal interviews 
were scheduled over email with the interviewer being as flexible as possible to the interviewees’ 
schedules. Interviews were conducted in both English and French, with the interviewee choosing 
their preferred language. The interviewer is fluent in English and proficient in French. Whenever 
possible, interviews were recorded to allow the interviewer to review what was said and to limit 
misunderstanding from language barriers. However, interviews were only recorded with the 
permission and consent of the participating expert. No outside translator was used.  
 Given that those interviewed often had a specific focus to their work (i.e. either AIDS or 
drug use, but usually not both), interview questions were tailored to the expertise of the 
interviewee. A master list of questions was created in both French and English. Questions that 
were most relevant to the expert’s field of work were then selected before each interview. 
Clarifying and further questions were also asked during the interview as needed.  
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 Secondary research provides a theoretical basis and historical context to this paper. 
Sources were primarily identified through online databases provided by Brown University. The 
key terms used in this literature review include: Needle Exchange Programs, Switzerland, Harm 
Reduction, United States, HIV and Harm Reduction, HIV and Needle Exchange Programs. 
Journal articles and reports were selected based on their relevancy to the topic and countries. 
Though some reports provide an important global context, most of the papers focus on either 
Switzerland or the USA. Though some papers were written before 2000, I focused my research 
on papers written after the year 2000 in order to ensure the currency and relevancy of the 
information provided.  
Theoretical Framework  
 This paper explores interventions based on a harm reduction framework. According to 
Harm Reduction International, harm reduction works “primarily to reduce the adverse health, 
social and economic consequences of the use of legal and illegal psychoactive drugs” through a 
variety of policies and programs.20 It is a philosophy of public health that stands in direct 
contradiction to repression-based policies. Harm reduction focuses on a pragmatic approach to 
limiting the danger associated with certain behaviors by providing help rather than relying on 
punishment. This framework accepts incremental changes rather than immediate and total 
abstinence.21 As Mireille Wehrli of Aspasie described, harm reduction often operates under the 
assumption that it is easier to control an activity or behavior if that behavior. When something 
like drug use or prostitution is criminalized within a country, people hide themselves to avoid 
law enforcement officials but also then restrict themselves from available resources. Public 
Health practitioners have a more difficult time gaining access to marginalized persons when they 
                                                 




are afraid of being arrested.22 Harm reduction is human-rights based approach to public health 
that recognizes that drug addiction is “a complex health condition that has a mixture of causes” 
and is not simply a moral defect on the part of users. 23 
 Needle Exchange Programs, also known as Needle Syringe Programs (NSP) and Syringe-
Exchange Programs (SEP), are key components to a harm reduction approach to drug use.  
Freddy Muller, the supervisor of Tremplin, an NEP in Fribourg, Switzerland describes that the 
primary function of these programs is to allow people to exchange a used, dirty needle for a 
clean, sterile one in order to limit the transmission of blood-borne diseases such as HIV and 
hepatitis C.24 These programs exist globally and may operate legally or illegally, depending on 
the laws of the locality. They can be run by health departments, governments, or private/non-
profit organizations.25Though the main function of NEPs is to provide injection drug users with 
clean syringes, they may also provide other services like counseling programs and access to 
harm reduction materials. Less common services include shower facilities, food and cafeterias 
for clients, and supervised drug-consumption rooms.  
 Even when NSPs are present within a community, they may not be fully utilized for a 
variety of reasons. Clients of these sites often report that “location, adequate space and hours of 
operation” are the biggest barriers to access the services.26 There is often conflict about where 
NEPs are located because the programs try to find areas of the city that are easily accessible to 
IDUs, but the general population does not want to have an NEP located in that area. NEPs must 
also work to be respectful of the humanity of their clients. Many patients report that they avoid 
the programs until emergency situations because they have had “humiliating, degrading, [and] 
                                                 
22 Wehrli, Formal Interview with Aspasie. 
23 “War on Drugs.” p. 6  
24 Muller, Formal Interview with Tremplin. 
25 DeSimone, “Needle Exchange Programs and Drug Injection Behavior.” 
26 Strike et al., “Needle Exchange Programs: Delivery and Access Issues.” P.340  
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unhelpful” experiences with past NSPs.27 According to Strike et al., needle exchange programs 
are constructed in a variety of ways in order to fit the needs of the population they are serving. 
Practitioners may locate at fixed sites or create mobile programs within a city. In some rarer 
cases, needle exchanges are even offered through home visits.28 
 Though other STIs and diseases can be transmitted through the sharing of injection 
materials, this paper will focus on HIV and AIDS.   
Analysis   
Historical, Cultural, and Political forces in Switzerland  
Although all of Europe experienced increased drug use during the 1960s and the 1970s as 
the counter-culture movement proliferated globally, “the increase was more dramatic in 
Switzerland” compared to neighboring countries for unknown reasons.29 Despite a strict drug 
law enacted in 1975 that declared “possession and use of drug to be illegal”, thus centering Swiss 
law on repression over harm reduction, the amount of IV drug use in the country continued to 
grow uncontrollably.30 The number of people using drugs injection drugs in Switzerland grew by 
20,000 in just seven years, from around 10,000 people in 1985 to over 30,000S in 1992.31 
Injection drug use was starkly prominent in Zurich’s Platzspitz Park, which was also referred to 
as the “needle park” and often had over 2000 people gathering there daily to inject drugs.32 
Unable to control this illegal drug use, the government decided that it “would tolerate IV drug 
                                                 
27 Ibid. p.340  
28 Ibid.   
29 Csete and Grob, “Switzerland, HIV and the Power of Pragmatism: Lessons for Drug Policy 
Development.” p. 83  
30 Somaini and Grob, “Commentary: How and Why AIDS Changed Drug Policy in Switzerland.” p.328  
31 Csete and Grob, “Switzerland, HIV and the Power of Pragmatism: Lessons for Drug Policy 
Development.”p. 83  
32 Somaini and Grob, “Commentary: How and Why AIDS Changed Drug Policy in Switzerland.” 
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users” within Platzspitz Park, a definite sign of their struggling ability to enforce a repression-
based policy.33  
During the 1980s, Switzerland was forced to simultaneously with the rapidly increasing 
use of injection drugs and the emerging AIDS epidemic. The first case of AIDS in Switzerland 
was diagnosed in 1982 and Switzerland “had the highest rate of newly diagnosed HIV infections 
in Europe” by the late 1980s.34 Andreas Lehner, an Executive Director of the Swiss AIDS 
Federation (SAF) attributes this higher prevalence to Switzerland’s wealth and “historical” 
legacy of non-repressive policies. According to Mr. Lehner, there were not many “other cities in 
Europe where there were so many rich people who [could] pay to visit America.”35 By 1985, 39 
cases had been reported, mainly among men who had “a history of sexual contact” with men 
from the United States.36  
In this same year, the first case of AIDS was reported in an injection drug user. After 
serologic tests were developed, it was found that drug users had around a 40% infection rate for 
HIV. 37 HIV and other blood borne infections were being transmitted at alarmingly high rates 
because of injection drug use. The sharing of used needles between IDUs “was the most 
significant pathway for transmitting HIV, HBV, and hepatitis C” for Switzerland.38 Recognizing 
the severity of the situation and the possibility for increasing rates of transmission, private and 
public actors sprang into action across Switzerland. Working in direct violation of federal law 
“300 medical doctors in Zurich declared their commitment” to creating and maintaining NEPs so 
                                                 
33 Ibid. p.319 
34 Dubois-Arber et al., “Trends in Drug Consumption and Risk of Transmission of HIV and Hepatitis C 
Virus among Injecting Drug Users in Switzerland, 1993-2006.” p.1  
35 Lehner, Formal Interview with Swiss Aids Federation. 
36 Somaini and Grob  p.318  
37 Ibid. p.318  
38 Ibid. p.319  
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that IDUs would have increased access to sterile syringes.39 Additional needle exchange 
programs were supported in Zurich by universities, the Swiss Red cross, and the governmental 
health unit of the city. Again, in direct violation of federal law, “local police stopped confiscating 
needles and syringes” from injection drug users. 40 Finally, a pilot program call ZIPP-AIDS 
(Zurich Intervention Pilot Project against AIDS) was introduced in the late 1980s. According to 
Somaini and Grob ZIPP-AIDS “profoundly influenced the future of Swiss drug policy” by 
promoting the understanding of injection drug users by community members and policy 
makers.41 Needle exchange programs and the harm reduction framework spread around 
Switzerland through the help of NGOs and city governments.  
In fact, though legally Switzerland only recognized a punitive approach to drugs, by 1994 
the country was implementing, in practice, a four-pillar approach based on “repression, 
prevention, harm reduction and treatment.”42 According to Somaini and Grob, it is imperative to 
“understand the Swiss government structure” and the “extent of decentralization” within 
Switzerland in particular, in order to be able to fully contextualize the Swiss response to the 
AIDS epidemic.43 Switzerland is a direct democracy which allows “national policy decisions” to 
be brought to a popular vote through national referendums.44 Mr. Simon of CHUV and 
COROMA, like many of the experts interviewed for this paper, emphasized that the Swiss 
system of enacting laws moves very slowly but the final results are typically quite good and 
                                                 
39 Csete and Grob, “Switzerland, HIV and the Power of Pragmatism: Lessons for Drug Policy 
Development.” p.83  
40 Somaini and Grob, “Commentary: How and Why AIDS Changed Drug Policy in Switzerland.” p.320  
41 Ibid. p.321  
42 Ibid. p.321  
43 Ibid. p.318  
44 Csete and Grob, “Switzerland, HIV and the Power of Pragmatism: Lessons for Drug Policy 
Development.” p.84  
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supported by the Swiss people. The process of direct democracy gives Switzerland the 
opportunity to carefully craft its legislation and to garner public support.45  
Multiple national referendums regarding drug use and harm reduction programs have 
been brought up in the past 25 years in Switzerland. The first referendum was about a policy 
called “Youth Without Drugs” which was purely abstinence-focused and would have 
criminalized all drug use and possession. The second referendum, called “Droleg”, was a 
complete reversal from Youth Without Drugs. This referendum asked the Swiss to legalize all 
drug use. Youth Without Drugs was rejected in 1997 by more than 70% of Swiss voters and 
Droleg was rejected in 1998 by more than 74% of voters. As a result, the unique Swiss 
referendum process showed popular support for a moderate and “pragmatic approach to drug 
policy.”46 
Though not officially enacted into law until 2008, the Swiss people have been in support 
of a more comprehensive and moderate system since the 1990s. For example. According to Mr. 
Ducret, Premiere Ligne has been in operation for the past 20 years. However, their existence 
only became legal with the 2008 vote. As such, Premiere Ligne existed illegally for over a 
decade with no interference from the government. This organization is located in a prominent 
building next to the busy train station in Geneva. Police officers often refer people caught using 
drugs to Premiere Ligne. Thus, we can see that the Swiss system has room for much flexibility. 
Though it takes time for laws to be decided upon, they are fully supported when they are voted 
in. 47 
 
Historical, Cultural, and Political forces in the United States of America  
                                                 
45 Simon, Formal Interview with COROMA. 
46 Somaini and Grob, “Commentary: How and Why AIDS Changed Drug Policy in Switzerland.”p.322  
47 Ducret, Formal Interview with Premiere Ligne. 
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 Whereas Switzerland had a dramatic and undeniable problem with injection drug use, the 
United States of America was blindsided by the AIDS epidemic and its perilous trajectory. Yet, 
despite the fact that AIDS has killed “more Americans than every conflict from World War II 
through Iraq,” and thus is comparable to the drastic open drug scenes which forced Switzerland 
to adopt harm reduction policies, the American reaction to this epidemic has been markedly 
different from that of Switzerland.48  AIDS first emerged in the USA over thirty years ago in 
1981. 49 However, this devastating disease remained largely ignored by the government and 
general population. Seen as “a disease that killed gay men and drug addicts,” AIDS was not an 
easy disease for the average American to sympathize with.50  
 Unlike in Switzerland, where efforts at Platzspits Park attempted to bridge the divide 
between the general community and the affected populations, in this case IDUs, Americans were 
reluctant to interact with people living with AIDS. Ronald Reagan, the president during the 
outbreak of the epidemic, waited until 1985, four years into the epidemic, to “discuss AIDS in a 
public forum” and did not actually use the word “AIDS” in public until 1987.51 The “fiscally and 
socially conservative climate” permeating American culture at this time certainly played a role in 
the detrimentally delayed reaction to the emerging epidemic.52  
 Eventually, in 1987, President Reagan created the Presidential Commission on the HIV 
Epidemic in order to respond to the crisis. This commission provided a set of comprehensive 
recommendations including treating substance abuse, promoting HIV testing, and protecting the 
rights of those who were identified to be HIV-positive. However, the President’s “lukewarm 
commitment to ensuring implementation” of these recommendations meant that they were 
                                                 
48 Jefferson, “How AIDS Changed America.” p.36  
49 Yehia and Frank, “Battling AIDS in America: An Evaluation of the National HIV/AIDS Strategy.” p.e4  
50 Jefferson, “How AIDS Changed America.” p.36  
51 Ibid. p.36  
52 Ibid. p.37  
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“largely ignored” and little work was done to advance the situation of people affected by 
HIV/AIDS.53 Since then, only two other presidents, President Clinton and President Obama, 
have released strategies for combatting the AIDS epidemic.  
 There has historically been a definite lack of vocal federal support for measures to 
support people living with HIV/AIDS.54 The conservative and puritanical foundations of 
American society have made it so that politicians are “loath to fund research into a new 
pathogen” that kills the undesirable populations of “gay men and intravenous drug 
users.”55These populations have typically been viewed as an affront to American moral norms 
and are thus seen as less deserving of funding and attention. While these sentiments clearly exist 
in Switzerland, as demonstrated by Andrea Verwohlt from UNAIDS’ comment that Swiss 
“people living with HIV may experience sometimes discrimination at work and in social 
relationships,” the Swiss federal government has intervened to create base levels of support for 
all citizens.56  
 The United States also has a history of focusing on punitive and abstinence-based 
measures that shame affected people and portray them as being morally defective. There is a 
“longstanding emphasis on drug law enforcement” and supply-side measures as the primary 
reactions for illegal drug use in the United States, strategies that can be traced back to 
Prohibition.57 The Eighteenth Amendment, ratified in 1920 and repealed in 1933, made alcohol, 
its sale, consumption, and manufacture, completely illegal within the borders to the United 
                                                 
53 Yehia and Frank, “Battling AIDS in America: An Evaluation of the National HIV/AIDS Strategy.”p.e4  
54 Ibid. p.34  
55 Jefferson, “How AIDS Changed America.” p.37  
56 Verwohlt, Formal Interview with UNAIDS. 
57 Hyshka et al., “Needle Exchange and the HIV Epidemic in Vancouver: Lessons Learned from 15 Years 
of Research.” p.262  
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States.58 Though the Eighteenth Amendment was only in place for 13 years, the issues of 
temperance and abstinence from any sort of drug use still continue today. This amendment 
signified a federal-level commitment to the practices of repression, creating a powerful historical 
legacy engrained in American culture.  
Prohibition can largely be seen as a reaction against changing American society at the 
time which was becoming “more urban, more secular, and more Catholic”, much to the distaste 
of the rural, deeply religious, Protestant groups who felt a claim over America’s moral 
authority.59 The movement pitted “urban, immigrant, lower class” Americans against the white, 
middle-class temperance advocates.60 Issues of class, race, religion, and citizen-ship status are 
deeply bred within the United States. Political and religious leaders such as Brent, Wright, 
Tenney and Hobson decried the moral scourge of drug and alcohol use and framed the debate in 
terms of racial and class differences. Newspapers during the Prohibition period were filled “with 
xenophobic headlines against ethnic minority groups” linking alcohol use to marginalized and 
less desirable populations.61 Attempts to control and limit drug use can be directly linked to 
white, financially secure, Anglo-Saxon Americans attempting to maintain their control over the 
American populous.  
 The United States of America has also constructed itself to be the moral leader of the 
world. Starting in the early 1900s, the US has attempted to maintain control over the global drug 
response. For example, in 1909 the US organized the first meeting of the International Opium 
commission “where 13 nations discussed the problems of the opium trade” globally.62 The US 
                                                 
58 Frendreis and Tatalovich, “A Hundred Miles of Dry.” 
59 Ibid. p. 304  
60 Ibid. p. 306  
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had an explicit interest in the global opium trade due to the fact that the Philippines was one of 
their colonies and had very “high levels of opium addiction” amongst the population.63 While the 
Prohibition movement was in full motion in the internal politics of the United States, politicians 
and religious leaders were working to extend this abstinence-based philosophy globally, such as 
through the Harrison Act of 1914 which is considered by experts to be “the cornerstone of global 
drug prohibition.”64  
 American foreign policy has only continued to rely on drug prohibition as a “means to 
transform other countries’ economics to promote the interests of US capital” through the modern 
age.65 The US uses the war on drugs as an excuse to “provide economic aid, training and security 
services”66, which thus allows the US to enter other states and assert its interests “through the 
notion of global self defence rather than interference.”67 According to Blackman, examples of 
the USA using drug prohibition as a means to enter and control a country can be seen in 
Afghanistan, Pakistan, Laos, Thailand, and Iran. America has dominated global conversations 
regarding drugs to the point where “the United Nations has adopted US style anti-drug policies 
on a global basis” 68 
  Clearly the international prominence of the United States’ prohibition-focused drug 
rhetoric requires that the country maintain strict drug policies domestically. Despite “conclusive 
scientific evidence” supporting needle exchange programs as an effective measure to reduce the 
harms associated with injection drug use, the US maintains federal opposition towards these 
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programs.69 The studies in Canada were “repeatedly cited as rationale for opposing NEPs” by US 
officials.70 In 2005, the paper regarding NEPs in Vancouver was cited by a congressional 
representative in an effort to limit US funding to international organizations that implement 
NEPs. As recently as 2011 “the US Congress reinstated a ban on federal needle exchange 
program funding.”71 However, even the authors of these studies in Vancouver have publicly 
stated that the United States is egregiously misinterpreting the results of their work. By 
continuing to cling onto these misinterpretations of on select study, and ignoring a large body of 
empirical evidence supporting the benefits of NEPs, the federal government is illustrating that is 
clearly “does not support the distribution of sterile syringes” as a viable policy. 72  
According to McLean, the lack of federal support for these programs stunts their 
implementation nationwide and has resulted in a “patchy and precarious” system of programs 
which are not sufficient for the entire affected population.73 By the end of 2002, NEPs were 
operating in only 36 states across the US. However, these programs were only legal in 12 of the 
states. Undoubtedly “like the earlier campaigns for temperance and prohibition”, drug 
prohibition has become a “symbolic crusade” against supposed moral defects.74 According to 
Buchanan, since the beginning of the founding of America, the people of America have felt like 
they are “God’s Chosen People” and “must live up to higher moral standards as a beacon to the 
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rest of the world.”75Such imperially moralistic viewpoints have created the US into a rigid 
supporter of drug prohibition, “despite international guidelines recommending NEPs as an 
essential HIV prevention program” and an overwhelming body of evidence supporting their 
efficacy. Despite hiding behind concerns of the results of these programs, it is clear that US 
opposition to these harm reduction strategies stems from a deeper cultural and political legacy 
within the US that seeks a global cultural domination.  
Current Situation regarding IDU and HIV/AIDS in Switzerland and USA  
Similarly to Switzerland, needle and syringe programs began in the US as “a fragmented 
and illegal practice” created by individuals who were willing to partake in acts of civil 
disobedience in order to protect the health and wellbeing of others.76 It is thought that one of the 
first needle exchange programs in the United States was created by Jon Stuen-Parker in 1983. 
Stuen-Parker, a student at Yale University and “former heroin user” started to distribute “sterile 
needles to intravenous drug users in New Haven, CT” despite the fact that this practice was 
illegal. 77 He, like many others practicing harm reduction methods around this time, was arrested 
multiple times for his efforts. Yet, Stuen-Parker and others across the country continued their 
work because they realized that not only do IDUs have an increased risk of being infected by a 
blood borne disease like HIV or hepatitis, they “can transmit these diseases to needle-sharing or 
sexual partners and their own children.”78 Thus, the public health implications of injection drug 
use are vast. Diseases can spread quickly through the population of IDUs and their social 
networks.  
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However, as noted by Freddy Muller of Tremplin, the Swiss system of needle exchanges 
grew into a reliable network of programs that has largely been successful in targeting the most 
vulnerable populations despite their illegal status. Whereas early activists were arrested in the 
United States for their work with needle exchange programs, the local governments of Zurich 
supported the programs once they realized the public health implications of failing to do so.79 
Andreas Lehner of SAF stressed that while the Swiss may be conservative, they are also very 
pragmatic. Ideological concerns reigned supreme in the United States and actually worsened the 
AIDS epidemic.80 
The Swiss government has steadily moved towards acceptance of these harm reduction.  
Yet, despite the fact that comprehensive studies have found “no evidence that NEPs increase 
drug use by clients or in communities” and huge benefits for the health of communities due to 
NEPs, the federal government of the United States continues to reinstate a ban on the use of 
federal funds for needle exchange programs.81 This ban has inhibited the creation of needle and 
syringe programs for injection drug users across the United States. Two years after the ban was 
instated in 1989, NEPs could only be found in the following US cities: “Portland, Tacoma, San 
Francisco, and occasionally, New York, New Haven, Philadelphia, and Boston.”82These 
operations were very small, often just one or two volunteers working at a curbside table.  
Though the situation has improved and NEPs can now be found in 36 states, they are still 
not widely accepted. Many NEPs must rely solely on local or private funding and are either 
“operating secretly” or “in tacit agreement with local law enforcement agencies.”83 The 
programs also remain limited in their ability to gain institutional legitimacy and as such many 
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continue to “operate at health van stops, sidewalk tables, cars, storefronts and health clinics” and 
hold limited hours, often only 20 hours per week. 84 These constraints prevent the NEPs from 
being as effective as they possibly can by limiting the ability of vulnerable populations to access 
their resources. As such, NEPs may seem less effective and then continue to lose support from 
surrounding communities.  
The government of the United States has “actively stigmatized drug users and 
criminalized outreach efforts” for years with disastrous results.85 The results of these restrictive 
policies are not decreased drug use or healthier communities. Rather, AIDS and HIV continue to 
present severe health concerns in many parts of the United States. While Switzerland has been 
able to essentially eliminate the transmission of HIV among injection drug users, the CDC 
“attributes 42 percent of U.S. cumulative nonpediatric AIDS cases through 2003” with injection 
drug use.86 Approximately three-quarters of these cases are directly linked to IDUs sharing 
needle. The remaining quarter of these cases are likely the result of unprotected sex with an IDU 
partner.87  
A global study of 81 cities, most of them American cities, “found that HIV infection rates 
among injectors decreased by 5.8 percent annually” in cities with needle exchange programs.88 
Cities without these programs saw a 5.9% average annual increase in the rate of HIV infection. 
There is also evidence to suggest that needle and syringe programs decrease the demand for 
drugs within a community by connecting clients with treatment and rehabilitative services. As 
such, the US has shown a callous disregard for the lives of injection drug users. NEPs are a 
tangible effort to improve a community’s health as well as symbolic commitment to the health 
                                                 
84 Ibid. p.560  
85 McLean, “The Biopolitics of Needle Exchange in the United States.” p.71  
86 DeSimone, “Needle Exchange Programs and Drug Injection Behavior.” p.559  
87 Ibid.  
88 Ibid. p.561  
House 25 
 
and wellbeing of injection drug users. DeSimone notes that the creation of needle exchange 
programs in a community “often reflects a broader commitment to HIV prevention among the 
users of injectable drugs” and can thus stand as a symbol of a government’s willingness to help 
its most marginalized populations. 89 
 In Switzerland, excellent and astounding progress has been to drastically contain the 
AIDS epidemic and open drug use. Platzspits Park, which 25 years ago was considered a scourge 
upon the city, has been transformed into a popular family-friendly park with playgrounds and 
even a small café. Furthermore, this transition was able to happen not at the expense of injection 
drug users, who are typically just moved from place to place rather than being actually helped, 
but to their benefit. Needle exchanges are open across Switzerland and are fairly easy to access. 
None of the interviewed experts believed that the exchanges were difficult to access due to their 
location predominantly in larger cities. Mr. Lehner of the Swiss AIDS Federation stated that they 
“don’t have AIDS anymore in Switzerland” due to all of the work that is done to prevent people 
from contracting HIV and the supports in place for people who are HIV positive.90 Pierre, a 
volunteer at Checkpoint Geneva recalled that the situation was completely different 30 years ago, 
when you commonly saw people dying from AIDS in the community. He described the horror of 
seeing these people who looked like “corpses” and were clearly suffering.91 The sources from 
Asile LGBT noted that while HIV is still affecting key populations, especially gay men, the 
changes over the past 30 years have been drastic.92 Mr. Ducret of Premiere Ligne reports that 
there was no seroconversion of any injection drug user in Geneva in the last year.93 Through 
campaigns like “Break the Chains”, which offer reduced-prices for HIV testing at the end of 
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May, groups like Asile LGBT Genève and the Swiss AIDS Federation are hoping to target the 
most vulnerable populations and have them be aware of their HIV status. 94  
 However, the situation in Switzerland is clearly not perfect. The experts seemed to have 
varying opinions about access to health care in general. Ms. Wehrli, a nurse with Aspasie, an 
organization that works with sex workers in Geneva, was very clear that her clients have 
insurance, pay their taxes, but they “n’ont pas d’accès aux soins.”95The base insurance plan that 
all people in Switzerland must have at a minimum has a deductible of 300 francs. However, 
consumers can decrease their premiums by accepting a deductible of up to 2000 francs. Mr. 
Olivier Simon believes that this base insurance is sufficient for his clients. He rarely has a patient 
who is unable to afford services, and in general the services covered for addiction medicine are 
comprehensive.96 Andrea Verwohlt also confirmed that “HIV/AIDS care is covered by Swiss 
health insurers” and assistance is available to those of lower economic means.97 
 However, according the Ms. Wehrli, the poorest members of society must have that 2000 
francs available, because they need to choose the option with the lowest premiums, if they want 
to access medical care. Such a cost is too high for her clients and, as a result, they forego care 
despite the fact that they have insurance.98  Mr. Lehrer, Mr. Ducret, and Mr. Husert all agreed 
that gay men were now the demographic group most affected by HIV. Mr. Husert of Checkpoint, 
a clinic specializing in providing testing and treatment for LGBTQ persons, also provided 
evidence that seems to contradict the opinions of Mr. Simon and Ms. Verwohlt. According to 
Mr. Huster, that the cost of an HIV test in Switzerland is 60 francs and PREP, a medication taken 
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before exposure to HIV in order to lessen the likelihood of seroconversion, costs around 900 
francs a month. These costs are not covered by insurance.99 Checkpoint is able to provide some 
free testing to sex workers and lower-income populations. Mr. Lehner stated that that getting 
people tested is “not a problem of the money” because of public funding that exists to care for 
these populations.100 However, access to PREP is more complicated and controversial.  
 There seems to be a large discrepancy in the opinions of the experts interviewed on the 
accessibility of services in Switzerland. While the system of obligatory insurance may succeed in 
adequately covering a large proportion of the Swiss population, there are clearly certain 
vulnerable populations that need additional support. Ms. Wehrli’s comments about the needs of 
her clients suggest that these low-income women are covered in theory but not in practice. More 
work may be needed in Switzerland to assure that all people have access to care in practice.  
 Switzerland does have an advantage being such a small country. Whereas the AIDS 
epidemic is spread out across the US, “70% of new HIV diagnosis among gay men is in Zurich,” 
a large city in Switzerland101 Within the United States HIV and AIDS can be found at its highest 
prevalence in “certain discrete geographic,” such as “urban areas of the Northeast and West 
Coast and cities and small towns in the South,” as well as within certain demographic groups.102  
The US currently has 1.1 million HIV positive people living within its borders and 21% of these 
people do not know that they are infected with HIV. 103 
  In 2006, the Center for Disease Control released new guidelines for HIV testing which 
states that all patients between the ages of 13 and 64 should be screened for HIV. However, 
despite the semblance of a cohesive national policy regarding HIV and AIDS, “conflicting state 
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laws” and “limited federal funding for testing programs” continue to prevent full 
implementation.104 The Obama administration has attempted to improve access to care through 
the implementation of the Affordable Care Act (ACA) which extends government health 
insurance to all people less than 65 years of age (people older than 65 are covered through 
Medicare) “with incomes up to 133% of the federal poverty level” through the Medicaid 
program. 105 However, though the NHAS has predicted that the amount of funding needed for 
HIV/AIDS programming is $15 billion, the “Obama administration has only dedicated $30 
million of the ACA Prevention and Public Health Fund” to HIV/AIDS prevention and 
programming.106 As such, these agencies are simply playing lip service to these crises and not 
actually providing enough support to end the epidemic. Like the Swiss insurance system, this 
expansion will theoretically extend coverage to all US citizens. However, high out-of-pocket 
costs still prevent access to care.  
 The unequal burden of AIDS and HIV in the US is appalling. While “the prevalence of 
HIV infection within some U.S. populations now rivals that in some sub-Saharan African 
countries”, the average rates of HIV are low for the general population. 107 Thus, HIV and AIDS 
are disproportionately affecting “the disenfranchised and socially marginalized” populations of 
America. 108 Recent studies have shown that the “rate of new AIDS cases is 9.7 times higher for 
Blacks and 3.3 times higher for Hispanics than for Whites”, indicating deep racial 
implications.109 
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 In New York City, one geographic hotspot for AIDS, “1 in 8 injection-drug users are 
HIV-infected.” 110The low social mobility of the affected populations makes it easier for 
politicians to ignore their needs. HIV and AIDS in America “has historically been framed as not 
only a matter of individual pathology, but also one of the national security and economic 
growth” because the most affected populations are viewed as dangerous to the innocence and 
purity of women and children. 111 
 It seems that this unequal burden of disease is not as prevalent in Switzerland, perhaps 
because the population is more homogenous or because HIV transmission has really been limited 
to within the gay community. None of the experts interviewed indicated racial disparities in the 
burden of HIV/AIDS in Switzerland. However, Mr. Lehner did note that because HIV is 
concentrated within the gay male population, little funding is given to support the health needs of 
gay women in Switzerland.  
Conclusion  
 After a study of the cultural, historical, and political forces at work in Switzerland and the 
USA, it has become quite clear that the responses that these countries have had to drug use and 
HIV/AIDS have been generated by their unique cultural and historical contexts. Though both 
countries are typically conservative with regards to drug use and sexuality, their responses to 
public health crises in the 1980s diverged from each other’s in such a way that has greatly 
impacted the current situation with regards to HIV and AIDS in each country. 
 Switzerland has made significant progress in controlling the public health crises of AIDS 
and injection drug use by employing a series of harm reduction methods. This country has 
essentially eliminated the transmission of HIV among injection drug users by reducing the rate of 
the sharing of injection materials. The main population still affected by HIV in Switzerland is 
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gay men. However, by focusing resources on gay men, Switzerland has limited the amount of 
resources that are available to women who are vulnerable to HIV. Ms. Wehrli’s comments 
regarding her work with sex workers indicate that further work needs to be done to ensure that 
the needs of marginalized women are met. 
 Milena Prvulovic from the UNDP indicated that though the Swiss are generally very 
accepting, programs about stigma and discrimination against people who have HIV and AIDS 
should “focus on service providers” and primarily medical providers.112 Her comments are 
supported by Mr. Husert of Checkpoint who noted that many gay men are uncomfortable going 
to their primary care physicians in Switzerland for sexual health-related matters for fear of being 
discriminated against.113Thus, as Mr. Ducret from Premiere Ligne stressed, the biggest task that 
Switzerland now faces is not forgetting the severity of the past drug and HIV epidemics. Now 
that open drug use and AIDS have been controlled within the country, people may forget the 
huge impacts that they had on Swiss citizens.114 Continued training of services providers, 
medical practitioners, and police officers is a critical component to maintaining the institutional 
memory surrounding injection drug use and HIV/AIDS.  
 
 Many experts interviewed stressed that the availability of resources can vary greatly from 
canton to canton in Switzerland. Though cantonal independence is an important feature of the 
Swiss political landscape, and matters of public health have traditionally fallen within the 
jurisdiction of the individual cantons, increased federal involvement in this arena would certainly 
improve equality in access to care. Residents of cantons that are historically more liberal, such as 
Vaud and Geneva, have a wider variety of options available to them, from needle exchange 
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programs, to methadone replacement therapy, to drug consumption rooms. People in more rural 
or conservative areas are not only more likely to face societal stigma as a barrier to accessing 
care, but also often have fewer options of programs because their canton refuses to create needle 
exchanges. In order to ensure equal access to all Swiss citizens, it seems as the federal 
government will need to take a larger role in the creation of these types of facilities. Further work 
should be done to measure cantonal differences to document all potential inequalities.  
 The USA has decided to maintain a strict War on Drugs which focuses on punitive 
measures for a public health problem. By responding to injection drug use with “moral 
indignation,” the US has actually set itself up for failure.115 This country has not been able to 
eliminate drug use or HIV transmission through its repressive policies, and has actually increased 
transmission of HIV between IDUs in areas where needle exchange programs are illegal. The 
United States cannot even begin to work on the discrepancies between states before it develops a 
comprehensive federal policy which accepts harm reduction as a legitimate and beneficial 
manner with which to target drug use. The first step of such a program would be to revoke the 
ban on federal funding of needle exchange programs. Without this federal support of NEPs, the 
country cannot feasibly reduce the transmission of HIV/AIDS within its geographic and 
demographic hotspots.  
 Perhaps most critically, the United States has used its global influence and power to 
mandate that other countries follow its destructive path of repression-based drug policy. While 
the UN and organizations like the WHO have started to accept and support harm reduction-based 
approaches, the US has had a significant role in slowing this acceptance. For example, because 
of the United States’ influence in the UN and their strict drug policies, the “Un World Drugs 
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Report 2009 makes no reference to ‘spirit’, ‘reform’ or ‘harm reduction’”, whereas these terms 
are all referenced by the UN in a report they released in 2008. 116 Further work needs to be done 
to understand the impact that the US has had on other countries by directing global drug policies. 
The Swiss government has felt some pressure from the United States to reverse its drug policies 
but has been able to resist due to its high world position. However, Swiss neutrality has limited 
its role in protecting other countries, which receive aid from the US, from being cowed to the 
repressive philosophies of the U.S. Switzerland has greatly improved the health of its citizens by 
retaining a harm reduction framework. It now needs to support other countries to create these 
types of programs and to direct global narratives about drug use away from purely repression 
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